Literature DB >> 11454827

Management and outcome of cardiogenic shock complicating acute myocardial infarction in hospitals with and without on-site catheterisation facilities.

I M Barbash1, S Behar, A Battler, D Hasdai, V Boyko, S Gottlieb, J Leor.   

Abstract

OBJECTIVE: To determine whether the availability of on-site catheterisation and revascularisation facilities influenced hospital management and outcome of patients with acute myocardial infarction complicated by cardiogenic shock.
METHODS: Patients with acute myocardial infarction were enrolled prospectively in four nationwide surveys during 1992, 1994, 1996, and 1998. The characteristics, management, and outcome of patients with cardiogenic shock were compared between hospitals with on-site catheterisation facilities (group 1; 18 hospitals) and without such facilities (group 2; 8 hospitals).
RESULTS: Of 5351 patients with acute myocardial infarction, 254 (4.7%) developed cardiogenic shock. Group 1 patients (n = 186 of 3854; 4.6%) were younger (mean (SD) age, 69.6 (12) v 73.7 (10) years, p = 0.006) and had a lower proportion of women (36% v 52%, p = 0.03) than group 2 (n = 68 of 1243; 5.2%). There was no difference in other characteristics including the use of thrombolysis. Group 1 patients more often underwent coronary angiography (26% v 4%, p < 0.001), angioplasty (21% v 4%, p = 0.002), and intra-aortic balloon counterpulsation (28% v 4%, p < 0.001). Seven day mortality was lower among group 1 than among group 2 patients (61% v 77%, p = 0.02), even after age and sex adjustment (odds ratio (OR) 0.54; 95% confidence interval (CI) 0.28 to 1.02). This outcome benefit persisted at 30 days (74% v 88%, p = 0.01; OR 0.45, 95% CI 0.18 to 0.98), and at 6 months (80% v 90%, p = 0.06; OR 0.57, 95% CI 0.22 to 1.33).
CONCLUSIONS: The greater use of invasive and interventional procedures in hospitals with catheterisation facilities is associated with improved survival of patients with acute myocardial infarction complicated by cardiogenic shock. Immediate availability of invasive care facilities will improve the outcome of cardiogenic shock in the community setting.

Entities:  

Mesh:

Year:  2001        PMID: 11454827      PMCID: PMC1729837          DOI: 10.1136/heart.86.2.145

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study.

Authors:  P B Berger; D R Holmes; A L Stebbins; E R Bates; R M Califf; E J Topol
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

2.  Improved outcome of elderly patients (> or = 75 years of age) with acute myocardial infarction from 1981-1983 to 1992-1994 in Israel. The SPRINT and Thrombolytic Survey Groups. Secondary Prevention Reinfarction Israel Nifedipine Trial.

Authors:  S Gottlieb; U Goldbourt; V Boyko; G Barbash; L Mandelzweig; H Reicher-Reiss; S Stern; S Behar
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

3.  Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Authors:  J S Hochman; L A Sleeper; J G Webb; T A Sanborn; H D White; J D Talley; C E Buller; A K Jacobs; J N Slater; J Col; S M McKinlay; T H LeJemtel
Journal:  N Engl J Med       Date:  1999-08-26       Impact factor: 91.245

4.  Cardiogenic shock complicating acute myocardial infarction: the use of coronary angioplasty and the integration of the new support devices into patient management.

Authors:  G M Gacioch; S G Ellis; L Lee; E R Bates; M Kirsh; J A Walton; E J Topol
Journal:  J Am Coll Cardiol       Date:  1992-03-01       Impact factor: 24.094

5.  Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era.

Authors:  J R Bengtson; A J Kaplan; K S Pieper; N M Wildermann; D B Mark; D B Pryor; H R Phillips; R M Califf
Journal:  J Am Coll Cardiol       Date:  1992-12       Impact factor: 24.094

6.  Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators.

Authors:  J S Hochman; J Boland; L A Sleeper; M Porway; J Brinker; J Col; A Jacobs; J Slater; D Miller; H Wasserman
Journal:  Circulation       Date:  1995-02-01       Impact factor: 29.690

7.  Early and 1-year survival rates in acute myocardial infarction complicated by cardiogenic shock: a retrospective study comparing coronary angioplasty with medical treatment.

Authors:  H Eltchaninoff; C Simpfendorfer; I Franco; R E Raymond; P N Casale; P L Whitlow
Journal:  Am Heart J       Date:  1995-09       Impact factor: 4.749

  7 in total
  3 in total

1.  Unequal access to interventional cardiac care in Nova Scotia in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  J Mayich; Jafna L Cox; Karen J Buth; Jean-Francois Légaré
Journal:  Can J Cardiol       Date:  2006-03-15       Impact factor: 5.223

2.  A review of cardiogenic shock in acute myocardial infarction.

Authors:  L Khalid; S H Dhakam
Journal:  Curr Cardiol Rev       Date:  2008-02

3.  Delayed Care and Mortality Among Women and Men With Myocardial Infarction.

Authors:  Raffaele Bugiardini; Beatrice Ricci; Edina Cenko; Zorana Vasiljevic; Sasko Kedev; Goran Davidovic; Marija Zdravkovic; Davor Miličić; Mirza Dilic; Olivia Manfrini; Akos Koller; Lina Badimon
Journal:  J Am Heart Assoc       Date:  2017-08-21       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.